Will Europe Be Ready for the Treatment of Alzheimer's Disease?

The Lancet Neurology - United Kingdom
doi 10.1016/s1474-4422(18)30409-5
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors

Unknown

Publisher

Elsevier BV

Related search

fMRI Beyond the Clinic: Will It Ever Be Ready for Prime Time?

PLoS Biology
ImmunologyMolecular BiologyGeneticsBiochemistryMicrobiology Biological SciencesAgriculturalNeuroscience
2004English

The Future of Alzheimer's Disease Treatment

Aging Health
2006English

NICE Guidelines and the Treatment of Alzheimer's Disease: Evidence-Based Medicine May Be Discriminatory

British Journal of Psychiatry
MedicinePsychiatryMental Health
2001English

Modulation of Gamma-Secretase for the Treatment of Alzheimer's Disease

International Journal of Alzheimer's Disease
AgingCognitive NeuroscienceMolecular NeuroscienceNeurologyBehavioral NeuroscienceCellular
2012English

Potential Repurposing of Oncology Drugs for the Treatment of Alzheimer's Disease

BMC Medicine
Medicine
2013English

Rare Disease Landscape: Will the Blockbuster Model Be Replaced?

Expert Opinion on Orphan Drugs
ToxicologyPharmaceuticsPharmacologyHealth Policy
2014English

Recent Tau-Targeted Clinical Strategies for the Treatment of Alzheimer's Disease

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2019English

Lack of Support for Bexarotene as a Treatment for Alzheimer's Disease

Neuropharmacology
Molecular NeuroscienceCellularPharmacology
2016English

Review of the Evidence That Transcranial Electromagnetic Treatment Will Be a Safe and Effective Therapeutic Against Alzheimer’s Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy